ABBVIE STEMCENTRX LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 5383
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 49206
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 25181
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2178
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0067,120 IDENTIFICATION AND ENRICHMENT OF CELL SUBPOPULATIONSSep 08, 17Mar 08, 18[A61K, C12N, G01N]
2018/0044,415 ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USEFeb 23, 16Feb 15, 18[A61K, C12N, C07K]
2017/0334,991 ANTI-CLDN CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USENov 04, 15Nov 23, 17[C07K]
2017/0320,960 NOVEL ANTI-MFI2 ANTIBODIES AND METHODS OF USESep 04, 15Nov 09, 17[A61K, C12Q, G01N, C07K]
2017/0307,622 KITS CONTAINING DLL3 ANTIBODY DRUG CONJUGATESJun 07, 17Oct 26, 17[A61K, G01N, C07K]
2017/0274,094 DLL3 MODULATORS AND METHODS OF USEJun 07, 17Sep 28, 17[A61K, G01N, C07K]
2017/0073,430 NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USEApr 21, 15Mar 16, 17[A61K, C07K]
2016/0175,460 ENGINEERED ANTI-DLL3 CONJUGATES AND METHODS OF USEFeb 29, 16Jun 23, 16[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914784 PTK7 modulators and methods of useMar 30, 16Mar 13, 18[A61K, C07K]
9878053 Methods of delivering DLL3 antibody drug conjugatesMay 30, 17Jan 30, 18[A61K, C12P, G01N, C07K]
9872922 Anti-EFNA4 antibody-drug conjugatesJun 08, 16Jan 23, 18[A61K, C07K]
9867887 Anti-DLL3 antibody drug conjugatesSep 01, 17Jan 16, 18[A61K, C12P, G01N, C07K]
9861708 Kits containing DLL3 antibody drug conjugatesJun 07, 17Jan 09, 18[A61K, C12P, G01N, C07K]
9855343 Anti-DLL3 antibody drug conjugatesJun 07, 17Jan 02, 18[A61K, C12P, G01N, C07K]
9775916 Anti-DLL3 antibody drug conjugates for treating cancerMay 30, 17Oct 03, 17[A61K, C12P, G01N, C07K]
9777070 Anti-PTK7 antibody-drug conjugatesApr 27, 15Oct 03, 17[A61K, C07K]
9777071 Anti-DPEP3 antibodies and methods of useOct 21, 16Oct 03, 17[A61K, C07K]
9778264 Identification and enrichment of cell subpopulationsAug 07, 14Oct 03, 17[A61K, C12N, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0322,166 NOTUM PROTEIN MODULATORS AND METHODS OF USEAbandonedMay 06, 15Nov 12, 15[C07K]
2013/0224,191 NOTUM PROTEIN MODULATORS AND METHODS OF USEAbandonedAug 26, 11Aug 29, 13[G01N, C07K]
2013/0058,947 Novel Modulators and Methods of UseAbandonedFeb 08, 12Mar 07, 13[A61K, C07H, A61P, C07K]
2013/0061,340 Identification and Enrichment of Cell SubpopulationsAbandonedMar 07, 12Mar 07, 13[C12Q, C12N, G01N, A01K, C40B]
2013/0061,342 Identification and Enrichment of Cell SubpopulationsAbandonedFeb 08, 12Mar 07, 13[C12N, A01K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.